Supplemental material
Open access
3,636
Views
13
CrossRef citations to date
0
Altmetric
Original Research
Additive immunosuppressive effect of leflunomide and hydroxychloroquine supports rationale for combination therapy for Sjögren’s syndrome
Eefje HM van der HeijdenDepartment of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands;Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The NetherlandsView further author information
, Sarita AY HartgringDepartment of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands;Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The NetherlandsView further author information
, Aike A KruizeLaboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The NetherlandsView further author information
, Timothy RDJ RadstakeDepartment of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands;Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The NetherlandsCorrespondence[email protected]
View further author information
& View further author information
Joel AG van RoonDepartment of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands;Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, The NetherlandsView further author information
Pages 801-808
|
Received 25 Mar 2019, Accepted 24 May 2019, Published online: 13 Jun 2019
Related Research Data
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study
Source:
Springer Nature
Type I Interferon in Sjögren's Syndrome
Source:
Wiley
Sjögren's Syndrome
Source:
Annual Reviews
Induction of Th1-Biased T Follicular Helper (Tfh) Cells in Lymphoid Tissues during Chronic Simian Immunodeficiency Virus Infection Defines Functionally Distinct Germinal Center Tfh Cells
Source:
The American Association of Immunologists
Ectopic lymphoid neogenesis in rheumatic autoimmune diseases
Source:
Springer Nature
Rituximab Therapy For Primary Sjögren's Syndrome
Source:
Wiley
Additive immunosuppressive effect of leflunomide and hydroxychloroquine supports rationale for combination therapy for Sjögren’s syndrome
Source:
Figshare
Mechanisms of Disease: primary Sjögren's syndrome and the type I interferon system
Source:
Springer Nature
Autophagy inhibitors
Source:
Springer Science and Business Media LLC
Effects of Hydroxychloroquine on Symptomatic Improvement in Primary Sjögren Syndrome
Source:
American Medical Association (AMA)
The Role of Ectopic Germinal Centers in the Immunopathology of Primary Sjögren's Syndrome: A Systematic Review
Source:
Elsevier BV
Optimizing conventional DMARD therapy for Sjögren's syndrome
Source:
Elsevier BV
REGULATION OF B CELL FUNCTION BY THE IMMUNOSUPPRESSIVE AGENT LEFLUNOMIDE1
Source:
Ovid Technologies (Wolters Kluwer Health)
B cell reconstitution and T helper cell balance after rituximab treatment of active primary Sjögren's syndrome: A double-blind, placebo-controlled study
Source:
Wiley-Blackwell
IL-12 induced the generation of IL-21- and IFN-γ-co-expressing poly-functional CD4+ T cells from human naive CD4+ T cells
Source:
Informa UK Limited
Type I IFN Induces Binding of STAT1 to Bcl6: Divergent Roles of STAT Family Transcription Factors in the T Follicular Helper Cell Genetic Program
Source:
The American Association of Immunologists
B Cell Depletion Therapy Normalizes Circulating Follicular Th Cells in Primary Sjögren Syndrome
Source:
The Journal of Rheumatology
Additive immunosuppressive effect of leflunomide and hydroxychloroquine supports rationale for combination therapy for Sjögren’s syndrome
Source:
Figshare
Type I and II interferon signatures in Sjogren's syndrome pathogenesis: Contributions in distinct clinical phenotypes and Sjogren's related lymphomagenesis
Source:
Elsevier BV
Treatment of Primary Sjögren Syndrome With Rituximab
Source:
American College of Physicians
New insights into mechanisms of therapeutic effects of antimalarial agents in SLE
Source:
Springer Nature
Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy.
Source:
Informa Healthcare
Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines
Source:
The American Association of Immunologists
Purification of human dihydro-orotate dehydrogenase and its inhibition by A77 1726, the active metabolite of leflunomide
Source:
Portland Press Ltd.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.